CMQ 0.00% 8.3¢ chemeq limited

why the pessimism, page-2

  1. 349 Posts.
    Your conspiracy theory about big pharmas blocking regulatory approval is pie in the sky, the real reason is amateurish bungles by the company. They have repeatedly sacked competent people working on their approvals and thus caused a breakdown in continuity, confusion and delays, then finally the appointment of a stooge in the position.

    Pricing will not help the fact that competitors to the product are catching up and also that the product is not a full substitute for antibiotics but only a substitute for gastrointestinal problems.
 
watchlist Created with Sketch. Add CMQ (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.